Evaluation of four chatbots in autoimmune liver disease: A comparative analysis.

Journal: Annals of hepatology
Published Date:

Abstract

INTRODUCTION AND OBJECTIVES: Autoimmune liver diseases (AILDs) are rare and require precise evaluation, which is often challenging for medical providers. Chatbots are innovative solutions to assist healthcare professionals in clinical management. In our study, ten liver specialists systematically evaluated four chatbots to determine their utility as clinical decision support tools in the field of AILDs.

Authors

  • Jimmy Daza
    Division of Hepatology, Division of Clinical Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Lucas Soares Bezerra
    Division of Hepatology, Division of Clinical Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Laura Santamaría
    Universidad de Los Andes School of Medicine, Bogotá, Colombia.
  • Roberto Rueda-Esteban
    Universidad de Los Andes School of Medicine, Bogotá, Colombia.
  • Heike Bantel
    Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Marcos Girala
    Department of Gastroenterology, Hospital de Clínicas, Universidad Nacional de Asunción, Asunción, Paraguay.
  • Matthias Ebert
    Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Clinical Cooperation Unit Healthy Metabolism, Center for Digital Medicine and Prevention, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Florian Van Bömmel
    Department of Medicine II, Clinic of Gastroenterology, Hepatology, Infectious Diseases and Pneumology, Leipzig University Medical Center, Leipzig, Germany.
  • Andreas Geier
    Department of Internal Medicine II, Division of Hepatology, University Hospital Würzburg, Würzburg, Germany.
  • Andres Gomez Aldana
    Texas Liver Institute, University of Texas Health Science Center, San Antonio, United States.
  • Kevin Yau
    Division of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Mario Alvares-da-Silva
    Department of Gastroenterology, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Markus Peck-Radosavljevic
    Internal Medicine and Gastroenterology (IMuG), Clinic Klagenfurt am Woerthersee, Klagenfurt, Austria.
  • Ezequiel Ridruejo
    Department of Medicine, Section of Hepatology, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno "CEMIC", Buenos Aires, Argentina.
  • Arndt Weinmann
    Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Andreas Teufel
    Division of Hepatology, Division of Clinical Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Clinical Cooperation Unit Healthy Metabolism, Center for Digital Medicine and Prevention, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. Electronic address: andreas.teufel@medma.uni-heidelberg.de.

Keywords

No keywords available for this article.